Portola Pharmaceuticals inc
Officers & Directors
1. Scott M. Garland - CEO and President
Scott M. Garland has served as a member of Portola's board since 2018 and was appointed as the CEO and President in . Previously, he was the Executive Vice President and Chief Commercial Officer of Portola.
2. Tao Fu - EVP, Research and Development
Tao Fu joined Portola in 2015 and is responsible for leading research and development. He has over 20+ years of experience in the biopharmaceutical industry, previously serving as Vice President of Development Sciences at Amgen, Inc.
3. Mardi C. Dier - EVP and CFO
Mardi C. Dier has been Portola's CFO since 2015. Before joining Portola, she was the Senior Vice President and CFO at Avanir Pharmaceuticals.
4. Carmen V. Noyes - EVP, General Counsel and Secretary
Carmen V. Noyes joined Portola in 2014 and is responsible for managing legal affairs, corporate governance, and compliance. Prior to joining Portola, Carmen served as Vice President and Corporate Secretary at publicly traded biopharmaceutical companies.
5. Janet L. Dorling - SVP, Commercial Development
Janet L. Dorling joined Portola in 2018 and is responsible for the company's commercial development activities. Previously, she was Senior Vice President of Commercial at BioMarin Pharmaceutical Inc.
6. Tina B. Nova, Ph.D. - Chairman of the Board
Dr. Tina B. Nova has been a member of Portola's board since 2018 and was appointed as Chairman in 2020. She has over 20+ years of executive experience in the biotechnology industry, with expertise in commercialization and business development.
William Lis - Board member
William Lis has been a member of Portola's board since 2020. He is the CEO and Founder of Acorn Pacific Ventures, a venture capital firm that invests in technology and healthcare companies.
8. Kim D. Blickenstaff - Board member
Kim D. Blickenstaff has been a member of Portola's board since 2018. He has over 30+ years of experience in the medical device industry, including serving as President and CEO of Tandem Diabetes Care Inc.
9. John H. Johnson - Board member
John H. Johnson has been a member of Portola's board since 2015. He is a veteran biopharmaceutical executive with over 30+ years of experience in the industry, including serving as CEO of Dendreon Corporation and ImClone Systems.
Portola Pharmaceuticals inc currently has 354 employees.
|
